1.            Atanaskovic-Markovic M, Gomes E, Cernadas JR, et al. Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper. Pediatr Allergy Immunol. 2019;30(3):269-76.

2.           Bianchi A, Valluzzi R, Crisafulli G, et al. Drug-Induced Anaphylaxis in Children. Biomed 2024;12(3):527.

3.           Brockow K, Ardern-Jones MR, Mockenhaupt M, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019;74(1):14-27.

4.          Brockow K, Garvey LH, Aberer W, et al. Skin test concentrations for systemically administered drugs-An ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12.

5.            Broyles AD, Banerji A, Castells M. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts. J Allergy Clin Immunol Pract. 2020;8:S3-S15.

6.            Caimmi S, Caffarelli C, Saretta F, et al. Drug desensitization in allergic children. Acta Biomed. 2019;90(Suppl 3):20-29.

7.         Cavkaytar O, Arga M. NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies. J Asthma Allergy. 2022;15:1383-99.

8.         Cavkaytar O, Karaatmaca B, Cetinkaya PG, et al. Characteristics of drug-induced anaphylaxis in children and adolescents. Allergy Asthma Proc. 2017;38(5):e56-e63.

9.         Çelik GE, Dursun AB, Editörler. İlaç Aşırı Duyarlılık Reaksiyonlarına Yaklaşım: Ulusal Rehber güncellemesi 2019. Türkiye Ulusal Allerji ve Klinik İmmünoloji Derneği. Buluş Tasarım ve Matbaacılık Hizmetleri, Ankara, 2019, s: 41-87.

10.     Demir S, Olgac M, Unal D, Gelincik A, Colakoglu B, Buyukozturk S. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015;70(11):1461-1467.

11.        Demoly P, Adkinson NF, Brockow K, et al. International Consensus on drug allergy. Allergy: Eur J Allergy Clin Immunol. 2014;69(4):420-37.

12.        Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to IV nonionic iodinated contrast material in children. Am J Roentgenol. 2007;188(6):1643-1647.

13.        Felix MMR, Kuschnir FC, Boechat JL, Castells M. Recent findings on drug hypersensitivity in children. Front Allergy. 2024;5:1330517.

14.        Garvey LH, Dewachter P, Hepner DL, et al. Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations. Br J Anaesth. 2019;123(1):e50-e64.

15.        Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: Report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016;71(2):149-61.

16.    Jutel M, Agache I, Zemelka-Wiacek M, et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy. 2023;78(11):2851-74.

17.        Karaatmaca B, Sahiner UM, Sekerel BE, Soyer O. Perioperative hypersensitivity reactions during childhood and outcomes of subsequent anesthesia. Paediatr Anaesth. 2021;31(4):436-443.

18.    Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: A 2022 practice parameter update. J Allergy Clin Immunol. 2022;150(6):1333-93.

19.        Kitsos N, Cassimos D, Xinias I, Agakidis C, Mavroudi A. Management of antibiotic allergy in children: a practical approach. Allergol Immunopathol (Madr). 2022;50(5):30-8.

20.        Kowalik A, de Monestrol I, Sorjonen K, Brockow K, Gülen T. Antibiotic hypersensitivity in cystic fibrosis – Low frequency of anaphylaxis over 16 000 courses. Br J Clin Pharmacol. 2022;88(11):4845-53.

21.        Mahler V, Junker AC. Anaphylaxis to additives in vaccines. Allergo J Int. 2022;31(5):123-36.

22.        Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Saif MW. Hypersensitivity reactions associated with platinum antineoplastic agents: A systematic review. Met Based Drugs. 2010;2010:207084.

23.        Manieri E, Dondi A, Neri I, Lanari M. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review. Front Med (Lausanne). 2023;10:1108345.

24.        Markman MD M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17(4):1141-5.

25.        Mori F, Saretta F, Riscassi S, et al. Risk factors for drug hypersensitivity reactions in children. Ital J Pediatr 2024 50:1. 2024;50(1):1-10.

26.      Muraro A, Lemanske RF, Castells M, et al. Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy. 2017;72(7):1006-21.

27.        Park JS, In Suh D. Drug allergy in children: What should we know? Clin Exp Pediatr. 2020;63(6):203-10.

28.      Picard M, Robitaille G, Karam F, et al. Cross-Reactivity to Cephalosporins and Carbapenems in Penicillin-Allergic Patients: Two Systematic Reviews and Meta-Analyses. J Allergy Clin Immunol Pract. 2019;7(8):2722-2738.e5.

29.      Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O. Multiple Drug Hypersensitivity. Int Arch Allergy Immunol. 2017;172(3):129-38.

30.     Pirmohamed M. Personalized pharmacogenomics: Predicting efficacy and adverse drug reactions. Annu Rev Genomics Hum Genet. 2014;15:349-70.

31.     Romano A, Atanaskovic-Markovic M, Barbaud A, et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper. Allergy. 2020;75(6):1300-15.

32.        Santo S, Kapelushnik J, Moser AM. Hypersensitivity and Allergic Reations to L-Asparaginase in Childhood ALL. Blood. 2007;110(11):4331-2.

33.       Solensky R, Phillips EJ. Drug Allergy. In: Adkinson NF Jr, Bochner BS, Burks AW, et al., eds. Middleton’s Allergy: Principles and Practice. 9th ed. Philadelphia PA, Elsevier, 2020, s:1212–58.

34.        Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. JAMA Dermatol. 2013;149(9):1025-32.

35.        Tip IV Ağır İlaç Aşırı Duyarlılık Reaksiyonları. Dibek Mısırlıoğlu E, Damadoglu E, Cavkaytar Ö, (Editörler), Ağır İlaç Aşırı Duyarlılık Reaksiyonları: Türkiye Ulusal Rehberi 2020. Buluş Tasarım ve Matbaacılık Hizmetleri, Ankara, 2020, s: 69-180.

36.        Tugcu GD, Cavkaytar O, Sekerel BE, et al. Actual drug allergy during childhood: Five years’ experience at a tertiary referral centre. Allergol Immunopathol (Madr). 2015;43(6):571-8.

37.      Wang Z, Shaker M, Hsu Blatman K. Pearls for practice from the 2022 joint task force drug allergy practice parameter. Curr Opin Pediatr. 2023;35(3):368-79.     Schrijvers R, Phillips EJ. A New Year, A New Era in Drug Hypersensitivity—Looking Beyond the Classical Paradigms. J Allergy Clin Immunol Pract. 2024;12(5):1137-8.